Alphaviral Encephalitides

Vaccines for Biodefense and Emerging and Neglected Diseases

Volumn , Issue , 2009, Pages 339-359

  Weaver, Scott C ^a   Paessler, Slobodan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869866222     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369408-9.00021-4     Document Type: Chapter

References (195)

1. Aguilar M.J. Pathological changes in brain and other target organs of infant and weanling mice after infection with non-neuroadapted western equine encephalitis virus. Infect. Immun. 1970, 2:533-542.
2. Aguilar, P.V., Paessler, S., Carrara, A.S., Baron, S., Poast, J., Wang, E., Moncayo, A.C., Anishchenko, M., Watts, D., Tesh, R.B. and Weaver, S.C. Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J. Virol. 2005; 79(17): 11300-11310.
3. Aguilar P.V., Robich R.M., Turell M.J., O'Guinn M.L., Klein T.A., Huaman A., Guevara C., Rios Z., Tesh R.B., Watts D.M., Olson J., Weaver S.C. Endemic eastern equine encephalitis in the Amazon region of Peru. Am. J. Trop. Med. Hyg. 2007, 76:293-298.
4. Aguilar P.V., Weaver S.C., Basler C.F. Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J. Virol. 2007, 81:3866-3876.
5. Anishchenko M., Bowen R.A., Paessler S., Austgen L., Greene I.P., Weaver S.C. Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:4994-4999.
6. Anishchenko M., Paessler S., Greene I., Aguilar P.V., Carrara A.S., Weaver S.C. Generation and characterization of closely related epizootic and enzootic infectious cDNA clones for studying interferon sensitivity and emergence mechanisms of Venezuelan equine encephalitis. J. Virol. 2004, 78:1-8.
7. Aronson J.F., Grieder F.B., Davis N.L., Charles P.C., Knott T., Brown K., Johnston R.E. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus. Virology 2000, 270:111-123.
8. Azimi P., Grossman M. Encephalitis in boy from South Carolina. Pediatr. Infect. Dis. J. 1997, 16:824-825.
9. Baker E.F., Sasso D.R., Maness K., Prichard W.D., Parker R.L. Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study. Am. J. Vet. Res. 1978, 39:1627-1631.
10. Barber T.L., Walton T.E., Lewis K.J. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses. Am. J. Vet. Res. 1978, 39:621-625.
11. Bastian F.O., Wende R.D., Singer D.B., Zeller R.S. Eastern equine encephalomyelitis. Histopathologic and ultrastructural changes with isolation of the virus in a human case. Am. J. Clin. Pathol. 1975, 64:10-13.
12. Bauer R.W., Gill M.S., Poston R.P., Kim D.Y. Naturally occurring eastern equine encephalitis in a Hampshire weather. J. Vet. Diagn. Invest. 2005, 17:281-285.
13. Beaty B.J., Calisher C.H., Shope R.E. Arboviruses. Diagnostic procedures for viral, rickettsial and chlamydial infections 1989, American Public Health Association, Washington, DC. 6th ed. N.J. Schmidt, R.W. Emmons (Eds.).
14. Beck C.E., Wyckoff R.W.G. Venezuelan equine encephalomyelitis. Science 1938, 88:530.
15. Beckwith W.H., Sirpenski S., French R.A., Nelson R., Mayo D. Isolation of eastern equine encephalitis virus and West Nile virus from crows during increased arbovirus surveillance in Connecticut, 2000. Am. J. Trop. Med. Hyg. 2002, 66:422-426.
16. Bennett A.M., Elvin S.J., Wright A.J., Jones S.M., Phillpotts R.J. An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine. Vaccine 2000, 19:337-347.
17. Bennett A.M., Lescott T., Phillpotts R.J. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus. Viral. Immunol. 1998, 11:109-117.
18. Berge T.O., Banks I.S., Tigertt W.D. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells. Am. J. Hyg. 1961, 73:209-218.
19. Bianchi T.I., Aviles G., Monath T.P., Sabattini M.S. Western equine encephalomyelitis: virulence markers and their epidemiologic significance. Am. J. Trop. Med. Hyg. 1993, 49:322-328.
20. Bianchi T.I., Aviles G., Sabattini M.S. Biological characteristics of an enzootic subtype of western equine encephalomyelitis virus from Argentina. Acta Virol. 1997, 41:13-20.
21. Binder G.K., Griffin D.E. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 2001, 293:303-306.
22. Binn L.N., Sponseller M.L., Wooding W.L., Mcconnell S.J., Spertzel R.O., Yager E.H. Efficacy of an attenuated western encephalitis vaccine in equine animals. Am. J. Vet. Res. 1966, 27:1599-1604.
23. Bowen G.S., Calisher C.H. Virological and serological studies of Venezuelan equine encephalomyelitis in humans. J. Clin. Microbiol. 1976, 4:22-27.
24. Bradish C.J., Titmuss D. The effects of interferon and double-stranded RNA upon the virus-host interaction: studies with Togavirus strains in mice. J. Gen. Virol. 1981, 53:21-30.
25. Briceno Rossi A.L. Rural epidemic encephalitis in Venezuela caused by a group A arbovirus (VEE). Progr. Med. Virol. 1967, 9:176-203.
26. Brown A., Officer J.E. An attenuated variant of Eastern encephalitis virus: biological properties and protection induced in mice. Arch. Virol. 1975, 47:123-138.
27. Brown A., Vosdingh R., Zebovitz E. Attenuation and immunogenicity of ts mutants of Eastern encephalitis virus for mice. J. Gen. Virol. 1975, 27:111-116.
28. Burke D.S., Ramsburg H.H., Edelman R. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. J. Infect. Dis. 1977, 136:354-359.
29. Calisher C.H., Maness K.S. Laboratory studies of Venezuelan equine encephalitis virus in equines, Texas, 1971. J. Clin. Microbiol. 1975, 2:198-205.
30. Calisher C.H., Shope R.E., Brandt W., Casals J., Karabatsos N., Murphy F.A., Tesh R.B., Wiebe M.E. Proposed antigenic classification of registered arboviruses I. Togaviridae, Alphavirus. Intervirology 1980, 14:229-232.
31. Casamassima A.C., Hess L.W., Marty A. TC-83 Venezuelan equine encephalitis vaccine exposure during pregnancy. Teratology 1987, 36:287-289.
32. Charles P.C., Brown K.W., Davis N.L., Hart M.K., Johnston R.E. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Virology 1997, 228:153-160.
33. Charles P.C., Trgovcich J., Davis N.L., Johnston R.E. Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Virology 2001, 284:190-202.
34. Charles P.C., Walters E., Margolis F., Johnston R.E. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology 1995, 208:662-671.
35. Clark G.G., Dein F.J., Crabbs C.L., Carpenter J.W., Watts D.M. Antibody response of sandhill and whooping cranes to an eastern equine encephalitis virus vaccine. J. Wildl. Dis. 1987, 23:539-544.
36. Cole F.E., May S.W., Eddy G.A. Inactivated Venezuelan equine encephalomyelitis vaccine prepared from attenuated (TC-83 strain) virus. Appl. Microbiol. 1974, 27:150-153.
37. Cole F.E., McKinney R.W. Cross-protection in hamsters immunized with group A arbovirus vaccines. Infect. Immun. 1971, 4:37-43.
38. Cole F.E., Pedersen C.E., Robinson D.M., Eddy G.A. Improved method for production of attenuated Venezuelan equine encephalomyelitis (TC-83 strain) vaccine. J. Clin. Microbiol. 1976, 3:460-462.
39. Coppenhaver D.H., Singh I.P., Sarzotti M., Levy H.B., Baron S. Treatment of intracranial alphavirus infections in mice by a combination of specific antibodies and an interferon inducer. Am. J. Trop. Med. Hyg. 1995, 52:34-40.
40. Cupp E.W., Tennessen K.J., Oldland W.K., Hassan H.K., Hill G.E., Katholi C.R., Unnasch T.R. Mosquito and arbovirus activity during 1997-2002 in a wetland in northeastern Mississippi. J. Med. Entomol. 2004, 41:495-501.
41. Das D., Gares S.L., Nagata L.P., Suresh M.R. Evaluation of a Western Equine Encephalitis recombinant E1 protein for protective immunity and diagnostics. Antiviral. Res. 2004, 64:85-92.
42. Davis N.L., Brown K.W., Greenwald G.F., Zajac A.J., Zacny V.L., Smith J.F., Johnston R.E. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology 1995, 212:102-110.
43. Davis N.L., Grieder F.B., Smith J.F., Greenwald G.F., Valenski M.L., Sellon D.C., Charles P.C., Johnston R.E. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis. Arch. Virol. Suppl. 1994, 9:99-109.
44. Davis N.L., West A., Reap E., Macdonald G., Collier M., Dryga S., Maughan M., Connell M., Walker C., Mcgrath K., Cecil C., Ping L.H., Frelinger J., Olmsted R., Keith P., Swanstrom R., Williamson C., Johnson P., Montefiori D., Johnston R.E. Alphavirus replicon particles as candidate HIV vaccines. IUBMB Life 2002, 53:209-211.
45. Day J.F., Stark L.M. Eastern equine encephalitis transmission to emus ( Dromaius novaehollandiae) in Volusia County, Florida: 1992 through 1994. J. Am. Mosq. Control. Assoc. 1996, 12:429-436.
46. De la Monte S., Castro F., Bonilla N.J., Gaskin de Urdaneta A., Hutchins G.M. The systemic pathology of Venezuelan equine encephalitis virus infection in humans. Am. J. Trop. Med. Hyg. 1985, 34:194-202.
47. Deresiewicz R.L., Thaler S.J., Hsu L., Zamani A.A. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N. Engl. J. Med. 1997, 336:1867-1874.
48. Edelman R., Ascher M.S., Oster C.N., Ramsburg H.H., Cole F.E., Eddy G.A. Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84). J. Infect. Dis. 1979, 140:708-715.
49. Ehrenkranz N.J., Ventura A.K. Venezuelan equine encephalitis virus infection in man. Annu. Rev. Med. 1974, 25:9-14.
50. Elvin S.J., Bennett A.M., Phillpotts R.J. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus. J. Med. Virol. 2002, 67:384-393.
51. Farber S., Hill A., Connerly M.L., Dingle J.H. Encephalitis in infants and children caused by a virus of the eastern variety of equine encephalitis. JAMA 1940, 114:1725-1731.
52. Femster R. Outbreak of encephalitis in man due to the eastern virus of equine encephalomyelitis. N. Engl. J. Med. 1938, 28:1403-1410.
53. Femster R. Equine encephalitis in Massachusetts. N. Engl. J. Med. 1957, 257:701-704.
54. Ferguson J.A., Reeves W.C., Hardy J.L. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines. Am. J. Vet. Res. 1977, 38:425-430.
55. Ferguson J.A., Reeves W.C., Milby M.M., Hardy J.L. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Am. J. Vet. Res. 1978, 39:371-376.
56. Fillis C.A., Calisher C.H. Neutralizing antibody responses of humans and mice to vaccination with Venezuelan encephalitis (TC-83) virus. J. Clin. Microbiol. 1979, 10:544-549.
57. Finter N. Interferon as an antiviral agent in vivo: quantitative and temporal aspects of the production of mice against Semliki Forest virus. Br. J. Exp. Pathol. 1966, 47:361-371.
58. Franklin R.P., Kinde H., Jay M.T., Kramer L.D., Green E.G., Chiles R.E., Ostlund E., Husted S., Smith J., Parker M.D. Eastern equine encephalomyelitis virus infection in a horse from California. Emerg. Infect. Dis. 2002, 8:283-288.
59. Frolov I., Frolova E., Schlesinger S. Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA. J. Virol. 1997, 71:2819-2829.
60. Frolova E.I., Fayzulin R.Z., Cook S.H., Griffin D.E., Rice C.M., Frolov I. Roles of nonstructural protein nsP2 and alpha/beta interferons in determining the outcome of Sindbis virus infection. J. Virol. 2002, 76:11254-11264.
61. Garcia-Tamayo J., Carreno G., Esparza J. Central nervous system alterations as sequelae of Venezuelan equine encephalitis virus infection in the rat. J. Pathol. 1979, 128:87-91.
62. Garen P.D., Tsai T.F., Powers J.M. Human eastern equine encephalitis: immunohistochemistry and ultrastructure. Mod. Pathol. 1999, 12:646-652.
63. Garmashova N., Gorchakov R., Frolova E., Frolov I. Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription. J. Virol. 2006, 80:5686-5696.
64. Garmashova N., Gorchakov R., Volkova E., Paessler S., Frolova E., Frolov I. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J. Virol. 2007, 81:2472-2484.
65. Getting V. Equine encephalomyelitis in Massachusetts. N. Engl. J. Med. 1941, 224:999-1006.
66. Gibbons D.L., Vaney M.C., Roussel A., Vigouroux A., Reilly B., Lepault J., Kielian M., Rey F.A. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 2004, 427:320-325.
67. Goldfield M., Welsh J.N., Taylor B.F. The 1959 outbreak of eastern encephalitis in New Jersey. 5. The inapparent infection:disease ratio. Am. J. Epidemiol. 1968, 87:32-33.
68. Gorelkin L. Venezuelan equine encephalomyelitis in an adult animal host. An electron microscopic study. Am. J. Pathol. 1973, 73:425-442.
69. Gorelkin L., Jahrling P.B. Pancreatic involvement by Venezuelan equine encephalomyelitis virus in the hamster. Am. J. Pathol. 1974, 75:349-362.
70. Gottdenker N.L., Howerth E.W., Mead D.G. Natural infection of a great egret ( Casmerodius albus) with eastern equine encephalitis virus. J. Wildl. Dis. 2003, 39:702-706.
71. Greene I.P., Paessler S., Anishchenko M., Smith D.R., Brault A.C., Frolov I., Weaver S.C. Venezuelan equine encephalitis virus in the guinea pig model: evidence for epizootic virulence determinants outside the e2 envelope glycoprotein gene. Am. J. Trop. Med. Hyg. 2005, 72:330-338.
72. Greene I.P., Paessler S., Austgen L., Anishchenko M., Brault A.C., Bowen R.A., Weaver S.C. Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic Venezuelan equine encephalitis virus. J. Virol. 2005, 79:9128-9133.
73. Greenway T.E., Eldridge J.H., Ludwig G., Staas J.K., Smith J.F., Gilley R.M., Michalek S.M. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine. Vaccine 1995, 13:1411-1420.
74. Greenway T.E., Eldridge J.H., Ludwig G., Staas J.K., Smith J.F., Gilley R.M., Michalek S.M. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine. Vaccine 1998, 16:1314-1323.
75. Grieder F.B., Davis B.K., Zhou X.D., Chen S.J., Finkelman F.D., Gause W.C. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Virology 1997, 233:302-312.
76. Grieder F.B., Davis N.L., Aronson J.F., Charles P.C., Sellon D.C., Suzuki K., Johnston R.E. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology 1995, 206:994-1006.
77. Grieder F.B., Vogel S.N. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology 1999, 257:106-118.
78. Griffin D., Levine B., Tyor W., Ubol S., Despres P. The role of antibody in recovery from alphavirus encephalitis. Immunol. Rev. 1997, 159:155-161.
79. Griffin D.E. Alphaviruses. Fields' Virology 2007, Lippincott, Williams and Wilkins, New York. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
80. Hahn C.S., Lustig S., Strauss E.G., Strauss J.H. Western equine encephalitis virus is a recombinant virus. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:5997-6001.
81. Hanson R.P. An epizootic of equine encephalomyelitis that occurred in Massachusetts in 1831. Am. J. Trop. Med. Hyg. 1957, 6:858-862.
82. Hart M.K., Caswell-Stephan K., Bakken R., Tammariello R., Pratt W., Davis N., Johnston R.E., Smith J., Steele K. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Vaccine 2000, 18:3067-3075.
83. Hodgson L.A., Ludwig G.V., Smith J.F. Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors. Vaccine 1999, 17:1151-1160.
84. Hughes J.P., Johnson H.N. A field trial of a live-virus western encephalitis vaccine. J. Am. Vet. Med. Assoc. 1967, 150:167-171.
85. Hunt A.R., Roehrig J.T. Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. Virology 1985, 142:334-346.
86. Jackson A.C., Sengupta S.K., Smith J.F. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters. Vet. Pathol. 1991, 28:410-418.
87. Jahrling P.B., Navarro E., Scherer W.F. Interferon induction and sensitivity as correlates to virulence of Venezuelan encephalitis viruses for hamsters. Arch. Virol. 1976, 51:23-35.
88. Jahrling P.B., Stephenson E.H. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J. Clin. Microbiol. 1984, 19:429-431.
89. Jan J.T., Chatterjee S., Griffin D.E. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J. Virol. 2000, 74:6425-6432.
90. Jan J.T., Griffin D.E. Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication. J. Virol. 1999, 73:10296-10302.
91. Johnson K.M., Martin D.H. Venezuelan equine encephalitis. Adv. Vet. Sci. Comp. Med. 1974, 18:79-116.
92. Johnson K.M., Shelokov A., Peralta P.H., Dammin G.J., Young N.A. Recovery of Venezuelan equine encephalomyelitis virus in Panama. A fatal case in man. Am. J. Trop. Med. Hyg. 1968, 17:432-440.
93. Jones L.D., Bennett A.M., Moss S.R., Gould E.A., Phillpotts R.J. Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice. Virus Res. 2003, 91:255-259.
94. Jordan R.A., Wagner J.A., Mccrumb F.R. Eastern equine encephalitis: report of a case with autopsy. Am. J. Trop. Med. Hyg. 1965, 14:470-474.
95. Julander J.G., Siddharthan V., Blatt L.M., Schafer K., Sidwell R.W., Morrey J.D. Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology 2007, 360:454-460.
96. Kinney R.M., Chang G.J., Tsuchiya K.R., Sneider J.M., Roehrig J.T., Woodward T.M., Trent D.W. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5′-noncoding region and the E2 envelope glycoprotein. J. Virol. 1993, 67:1269-1277.
97. Kinney R.M., Esposito J.J., Johnson B.J., Roehrig J.T., Mathews J.H., Barrett A.D., Trent D.W. Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins. J. Gen. Virol. 1988, 69:3005-3013.
98. Kinney R.M., Esposito J.J., Mathews J.H., Johnson B.J., Roehrig J.T., Barrett A.D., Trent D.W. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J. Virol. 1988, 62:4697-4702.
99. Kinney R.M., Tsuchiya K.R., Sneider J.M., Trent D.W. Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969 to 1972. J. Gen. Virol. 1992, 73:3301-3305.
100. Kubes V., Rios F.A. The causitive agent of infectious equine encephalomyelitis in Venezuela. Science 1939, 90:20-21.
101. Kuhn R.J., Griffin D.E., Owen K.E., Niesters H.G., Strauss J.H. Chimeric Sindbis-Ross River viruses to study interactions between alphavirus nonstructural and structural regions. J. Virol. 1996, 70:7900-7909.
102. Kundin W.D. Pathogenesis of Venezuelan equine encephalomyelitis virus. II. Infection in young adult mice. J. Immunol. 1966, 96:49-58.
103. Leon C.A. Sequelae of Venezuelan equine encephalitis in humans: a four year follow-up. Int. J. Epidemiol. 1975, 4:131-140.
104. Lescar J., Roussel A., Wien M.W., Navaza J., Fuller S.D., Wengler G., Rey F.A. The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 2001, 105:137-148.
105. Liljestrom P., Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N.Y.) 1991, 9:1356-1361.
106. Liu C., Voth D.W., Rodina P., Shauf L.R., Gonzalez G. A comparative study of the pathogenesis of western equine and eastern equine encephalomyelitis viral infections in mice by intracerebral and subcutaneous inoculations. J. Infect. Dis. 1970, 122:53-63.
107. Locher C.P., Paidhungat M., Whalen R.G., Punnonen J. DNA shuffling and screening strategies for improving vaccine efficacy. DNA Cell Biol. 2005, 24:256-263.
108. London W.T., Levitt N.H., Kent S.G., Wong V.G., Sever J.L. Congenital cerebral and ocular malformations induced in rhesus monkeys by Venezuelan equine encephalitis virus. Teratology 1977, 16.
109. Ludwig G.V., Turell M.J., Vogel P., Kondig J.P., Kell W.K., Smith J.F., Pratt W.D. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Am. J. Trop. Med. Hyg. 2001, 64:49-55.
110. MacDonald G.H., Johnston R.E. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J. Virol. 2000, 74:914-922.
111. McClain D.J., Pittman P.R., Ramsburg H.H., Nelson G.O., Rossi C.A., Mangiafico J.A., Schmaljohn A.L., Malinoski F.J. Immunologic interference from sequential administration of live attenuated alphavirus vaccines. J. Infect. Dis. 1998, 177:634-641.
112. McKinney R.W., Berge T.O., Sawyer W.D., Tigertt W.D., Crozier D. Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man. Am. J. Trop. Med. Hyg. 1963, 12:597-603.
113. Meyer K.F., Haring C.M., Howitt B. The etiology of epizootic encephalomyelitis of horses in the San Joachin Valley, 1930. Science 1931, 74:227-228.
114. Monath T.P., Kemp G.E., Cropp C.B., Chandler F.W. Necrotizing myocarditis in mice infected with Western equine encephalitis virus: clinical, electrocardiographic, and histopathologic correlations. J. Infect. Dis. 1978, 138:59-66.
115. Morris C.D. Eastern equine encephalomyelitis. The Arboviruses: Epidemiology and Ecology 1988, Vol. III. CRC Press, Boca Raton, Florida. T.P. Monath (Ed.).
116. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
117. Nagata L.P., Hu W.G., Masri S.A., Rayner G.A., Schmaltz F.L., Das D., Wu J., Long M.C., Chan C., Proll D., Jager S., Jebailey L., Suresh M.R., Wong J.P. Efficacy of DNA vaccination against western equine encephalitis virus infection. Vaccine 2005, 23:2280-2283.
118. Nagata L.P., Hu W.G., Parker M., Chau D., Rayner G.A., Schmaltz F.L., Wong J.P. Infectivity variation and genetic diversity among strains of Western equine encephalitis virus. J. Gen. Virol. 2006, 87:2353-2361.
119. Nathanson N., Stolley P.D., Boolukos P.J. Eastern equine encephalitis. Distribution of central nervous system lesions in man and Rhesus monkey. J. Comp. Pathol. 1969, 79:109-115.
120. Olsen G.H., Turell M.J., Pagac B.B. Efficacy of eastern equine encephalitis immunization in whooping cranes. J. Wildl. Dis. 1997, 33:312-315.
121. Paessler S., Aguilar P., Anishchenko M., Wang H.Q., Aronson J., Campbell G., Cararra A.S., Weaver S.C. The hamster as an animal model for eastern equine encephalitis-and its use in studies of virus entrance into the brain. J. Infect. Dis. 2004, 189:2072-2076.
122. Paessler S., Fayzulin R.Z., Anishchenko M., Greene I.P., Weaver S.C., Frolov I. Recombinant Sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J. Virol. 2003, 77:9278-9286.
123. Paessler S., Ni H., Petrakova O., Fayzulin R.Z., Yun N., Anishchenko M., Weaver S.C., Frolov I. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. J. Virol. 2006, 80:2784-2796.
124. Paessler, S., Yun, N.E., Judy, B.M., Dziuba, N., Zacks, M.A., Grund, A.H., Frolov, I., Campbell, G.A., Weaver, S.C. and Estes, D.M. Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology 2007; 367(2):307-323.
125. Pedersen C.E. Preparation and testing of vaccines prepared from the envelopes of Venezuelan, eastern, and western equine encephalomyelitis viruses. J. Clin. Microbiol. 1976, 3:113-118.
126. Pedersen C.E., Robinson D.M., Cole F.E. Isolation of the vaccine strain of Venezuelan equine encephalomyelitis virus from mosquitoes in Louisiana. Am. J. Epidemiol. 1972, 95:490-496.
127. Pereboev A.V., Razumov I.A., Svyatchenko V.A., Loktev V.B. Glycoproteins E2 of the Venezuelan and eastern equine encephalomyelitis viruses contain multiple cross-reactive epitopes. Arch. Virol. 1996, 141:2191-2205.
128. Phillpotts R.J. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83. Vaccine 1999, 17:2429-2435.
129. Phillpotts R.J., Jones L.D., Howard S.C. Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus. Vaccine 2002, 20:1497-1504.
130. Phillpotts R.J., Lescott T.L., Jacobs S.C. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV. Acta Virol. 2000, 44:233-239.
131. Phillpotts R.J., O'Brien L., Appleton R.E., Carr S., Bennett A. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus. Vaccine 2005, 23:1615-1623.
132. Phillpotts R.J., Wright A.J. TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus. Vaccine 1999, 17:982-988.
133. Pittman P.R., Makuch R.S., Mangiafico J.A., Cannon T.L., Gibbs P.H., Peters C.J. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 1996, 14:337-343.
134. Pletnev S.V., Zhang W., Mukhopadhyay S., Fisher B.R., Hernandez R., Brown D.T., Baker T.S., Rossmann M.G., Kuhn R.J. Locations of carbohydrate sites on alphavirus glycoproteins show that E1 forms an icosahedral scaffold. Cell 2001, 105:127-136.
135. Polo J.M., Belli B.A., Driver D.A., Frolov I., Sherrill S., Hariharan M.J., Townsend K., Perri S., Mento S.J., Jolly D.J., Chang S.M., Schlesinger S., Dubensky T.W. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:4598-4603.
136. Powers A.M., Brault A.C., Kinney R.M., Weaver S.C. The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants. J. Virol. 2000, 74:4258-4263.
137. Pratt W.D., Davis N.L., Johnston R.E., Smith J.F. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. Vaccine 2003, 21:3854-3862.
138. Pratt W.D., Gibbs P., Pitt M.L., Schmaljohn A.L. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates. Vaccine 1998, 16:1056-1064.
139. Pushko P., Bray M., Ludwig G.V., Parker M., Schmaljohn A., Sanchez A., Jahrling P.B., Smith J.F. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 2000, 19:142-153.
140. Pushko P., Parker M., Ludwig G.V., Davis N.L., Johnston R.E., Smith J.F. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 1997, 239:389-401.
141. Randall R., Maurer F.D., Smadel J.E. Immunization of laboratory workers with purified Venezuelan equine encephalomyelitis vaccine. J. Immunol. 1949, 63:313-318.
142. Rao V., Hinz M.E., Roberts B.A., Fine D. Environmental hazard assessment of Venezuelan equine encephalitis virus vaccine candidate strain V3526. Vaccine 2004, 22:2667-2673.
143. Rayfield E.J., Gorelkin L., Curnow R.T., Jahrling P.B. Virus-induced pancreatic disease by Venezuelan encephalitis virus. Alterations in glucose tolerance and insulin release. Diabetes 1976, 25:623-631.
144. Reed D.S., Lackemeyer M.G., Garza N.L., Norris S., Gamble S., Sullivan L.J., Lind C.M., Raymond J.L. Severe encephalitis in cynomolgus macaques exposed to aerosolized eastern equine encephalitis virus. J. Infect. Dis. 2007, 196:441-450.
145. Reed D.S., Larsen T., Sullivan L.J., Lind C.M., Lackemeyer M.G., Pratt W.D., Parker M.D. Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques. J. Infect. Dis. 2005, 192:1173-1182.
146. Reed D.S., Lind C.M., Lackemeyer M.G., Sullivan L.J., Pratt W.D., Parker M.D. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. Vaccine 2005, 23:3139-3147.
147. Reed D.S., Lind C.M., Sullivan L.J., Pratt W.D., Parker M.D. Aerosol infection of cynomolgus macaques with enzootic strains of venezuelan equine encephalitis viruses. J. Infect. Dis. 2004, 189:1013-1017.
148. Reisen W.K. Western equine encephalitis. The Encyclopedia of Arthropod-transmitted Infections 2001, CAB International, Wallingford, U.K. M.W. Service (Ed.).
149. Reisen W.K., Monath T.P. Western equine encephalomyelitis. The Arboviruses: Epidemiology and Ecology 1988, Vol. V. CRC Press, Boca Raton, Florida. T.P. Monath (Ed.).
150. Riemenschneider J., Garrison A., Geisbert J., Jahrling P., Hevey M., Negley D., Schmaljohn A., Lee J., Hart M.K., Vanderzanden L., Custer D., Bray M., Ruff A., Ivins B., Bassett A., Rossi C., Schmaljohn C. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine 2003, 21:4071-4080.
151. Rivas F., Diaz L.A., Cardenas V.M., Daza E., Bruzon L., Alcala A., De la Hoz O., Caceres F.M., Aristizabal G., Martinez J.W., Revelo D., De la Hoz F., Boshell J., Camacho T., Calderon L., Olano V.A., Villarreal L.I., Roselli D., Alvarez G., Ludwig G., Tsai T. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J. Infect. Dis. 1997, 175:828-832.
152. Roehrig J.T. Immunogens of encephalitis viruses. Vet. Microbiol. 1993, 37:273-284.
153. Roehrig J.T., Bolin R.A. Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of Subtype I Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay. J. Clin. Microbiol. 1997, 35:1887-1890.
154. Roehrig J.T., Hunt A.R., Chang G.J., Sheik B., Bolin R.A., Tsai T.F., Trent D.W. Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses. Am. J. Trop. Med. Hyg. 1990, 42:394-398.
155. Rowell J.F., Griffin D.E. Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis. J. Neuroimmunol. 2002, 127:106-114.
156. Rozdilsky B., Robertson H.E., Chorney J. Western encephalitis: report of eight fatal cases. Saskatchewan epidemic, 1965. Can. Med. Assoc. J. 1968, 98:79-86.
157. Ryzhikov A.B., Ryabchikova E.I., Sergeev A.N., Tkacheva N.V. Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch. Virol. 1995, 140:2243-2254.
158. Ryzhikov A.B., Tkacheva N.V., Sergeev A.N., Ryabchikova E.I. Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice. Biomed. Sci. 1991, 2:607-614.
159. Sammin D.J., Butler D., Atkins G.J., Sheahan B.J. Cell death mechanisms in the olfactory bulb of rats infected intranasally with Semliki forest virus. Neuropathol. Appl. Neurobiol. 1999, 25:236-243.
160. Schoepp R.J., Smith J.F., Parker M.D. Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates. Virology 2002, 302:299-309.
161. Schoneboom B.A., Fultz M.J., Miller T.H., Mckinney L.C., Grieder F.B. Astrocytes as targets for Venezuelan equine encephalitis virus infection. J. Neurovirol. 1999, 5:342-354.
162. Schoneboom B.A., Lee J.S., Grieder F.B. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice. J. Interferon Cytokine Res. 2000, 20:205-215.
163. Sidwell R.W., Smee D.F. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral. Res. 2003, 57:101-111.
164. Smith D.R., Aguilar P.V., Coffey L.L., Gromowski G.D., Wang E., Weaver S.C. Venezuelan equine encephalitis virus transmission and effect on pathogenesis. Emerg. Infect. Dis. 2006, 12:1190-1196.
165. Snoeyenbos G.H., Weinack O.M., Rosenau B.J. Immunization of pheasants for eastern encephalitis. Avian Dis. 1978, 22:386-390.
166. Spotts D.R., Reich R.M., Kalkhan M.A., Kinney R.M., Roehrig J.T. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5′ noncoding region and glycoproteins. J. Virol. 1998, 72:10286-10291.
167. Strizki J.M., Repik P.M. Differential reactivity of immune sera from human vaccinees with field strains of eastern equine encephalitis virus. Am. J. Trop. Med. Hyg. 1995, 53:564-570.
168. Sutton L.S., Brooke C.C. Venezuelan equine encephalomyelitis due to vaccination in man. J. Am. Med. Assoc. 1954, 155:1473-1476.
169. Tate C.M., Howerth E.W., Stallknecht D.E., Allison A.B., Fischer J.R., Mead D.G. Eastern equine encephalitis in a free-ranging white-tailed deer ( Odocoileus virginianus). J. Wildl. Dis. 2005, 41:241-245.
170. Ten Broeck C., Merrill M. A serological difference between eastern and western equine encephalomyelitis virus. Proc. Soc. Exp. Biol. Med. 1933, 31:217-220.
171. Tengelsen L.A., Bowen R.A., Royals M.A., Campbell G.L., Komar N., Craven R.B. Response to and efficacy of vaccination against eastern equine encephalomyelitis virus in emus. J. Am. Vet. Med. Assoc. 2001, 218:1469-1473.
172. Laboratory safety for arboviruses and certain other viruses of vertebrates. Am. J. Trop. Med. Hyg. 1980, 29:1359-1381. The Subcommittee on Arbovirus Laboratory Safety of the American Committee on Arthropod-Borne Viruses.
173. Thompson J.M., Whitmore A.C., Konopka J.L., Collier M.L., Richmond E.M., Davis N.L., Staats H.F., Johnston R.E. Mucosal and systemic adjuvant activity of alphavirus replicon particles. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3722-3727.
174. Tsai T.F., Weaver S.C., Monath T.P. Alphaviruses. Clinical Virology 2002, ASM Press, Washington, DC. D.D. Richman, R.J. Whitley, F.G. Hayden (Eds.).
175. Turell M.J., Ludwig G.V., Kondig J., Smith J.F. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates. Am. J. Trop. Med. Hyg. 1999, 60:1041-1044.
176. Turell M.J., Spielman A. Nonvascular delivery of Rift Valley fever virus by infected mosquitoes. Am. J. Trop. Med. Hyg. 1992, 47:190-194.
177. Biosafety in Microbiological and Biomedical Laboratories 1999, U.S. Department of Health and Human Services, U.S. Government Printing Office, Washington, DC. 4th ed.
178. Vanderwagen L.C., Pearson J.L., Franti C.E., Tamm E.L., Riemann H.P., Behymer D.E. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis. Am. J. Vet. Res. 1975, 36:1567-1571.
179. Villari P., Spielman A., Komar N., Mcdowell M., Timperi R.J. The economic burden imposed by a residual case of eastern encephalitis. Am. J. Trop. Med. Hyg. 1995, 52:8-13.
180. Vogel P., Kell W.M., Fritz D.L., Parker M.D., Schoepp R.J. Early events in the pathogenesis of eastern equine encephalitis virus in mice. Am. J. Pathol. 2005, 166:159-171.
181. Walder R., Jahrling P.B., Eddy G.A. Differentiation markers of eastern equine encephalitis (EEE) viruses and virulence. Arboviruses in the Mediterranean Countries 1980, Gustav Fischer Verlag, Stuttgart. J. Vesenjak-Hirjan (Ed.).
182. Waldridge B.M., Wenzel J.G., Ellis A.C., Rowe-Morton S.E., Bridges E.R., D'Andrea G., Wint R. Serologic responses to eastern and western equine encephalomyelitis vaccination in previously vaccinated horses. Vet. Ther. 2003, 4:242-248.
183. Walton T.E., Brautigam F.E., Ferrer J.A., Johnson K.M. Epizootic Venezuelan equine encephalomyelitis in Central America. Disease pattern and vaccine evaluation in Nicaragua, 1969-1970. Am. J. Epidemiol. 1972, 95:247-254.
184. Walton T.E., Grayson M.A. Venezuelan equine encephalomyelitis. The Arboviruses: Epidemiology and Ecology 1988, Vol. IV. CRC Press, Boca Raton, FL. T.P. Monath (Ed.).
185. Walton T.E., Johnson K.M. Persistence of neutralizing antibody in Equidae vaccinated with Venezuelan equine encephalomyelitis vaccine strain TC-83. J. Am. Vet. Med. Assoc. 1972, 161:916-918.
186. Wang E., Barrera R., Boshell J., Ferro C., Freier J.E., Navarro J.C., Salas R., Vasquez C., Weaver S.C. Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor. J. Virol. 1999, 73:4266-4271.
187. Wang, E., Petrakova, O., Adams, A.P., Aguilar, P.V., Kang, W., Paessler, S., Volk, S.M., Frolov, I. and Weaver, S.C. Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice. Vaccine 2007; 25(43):7573-7581.
188. Weaver S.C. Eastern equine encephalitis. The Encyclopedia of Arthropod-transmitted Infections 2001, CAB International, Wallingford, U.K. M.W. Service (Ed.).
189. Weaver S.C., Ferro C., Barrera R., Boshell J., Navarro J.C. Venezuelan equine encephalitis. Annu. Rev. Entomol. 2004, 49:141-174.
190. Weaver S.C., Frey T.K., Huang H.V., Kinney R.M., Rice C.M., Roehrig J.T., Shope R.E., Strauss E.G. Togaviridae. Virus Taxonomy, VIIIth Report of the ICTV 2005, Elsevier/Academic Press, London. C.M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball (Eds.).
191. Weaver S.C., Kang W., Shirako Y., Rumenapf T., Strauss E.G., Strauss J.H. Recombinational history and molecular evolution of western equine encephalomyelitis complex alphaviruses. J. Virol. 1997, 71:613-623.
192. Weaver S.C., Pfeffer M., Marriott K., Kang W., Kinney R.M. Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks. Am. J. Trop. Med. Hyg. 1999, 60:441-448.
193. Worthington M., Baron S. Late therapy with an interferon stimulator in an arbovirus encephalitis in mice. Proc. Soc. Exp. Biol. Med. 1971, 136:323-327.
194. Worthington M., Levy H., Rice J. Late therapy of an arbovirus encephalitis in mice with interferon and interferon stimulators. Proc. Soc. Exp. Biol. Med. 1973, 143:638-643.
195. Zhou X., Berglund P., Rhodes G., Parker S.E., Jondal M., Liljestrom P. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 1994, 12:1510-1514.